Search

everythinglearnresearchcommunity

for

Search:↓

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

The scalp fat tissue of men with hair loss shows changes in gene activity that may contribute to their condition.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

Different types of stem cells in the skin contribute to the variety of melanoma forms.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Cholesterol transport in hair follicles decreases from growth to regression phase.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Medications for PCOS don't seem to raise heart disease risk.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

PPARβ/δ helps yaks adapt to high altitudes by regulating lipid metabolism in their coats.

PPAR alpha may help in hair growth and could be a target for treatment.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

PPAR-γ signaling improves mitochondrial function in hair follicles, potentially affecting hair growth and aging.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

Dysregulated lipid metabolism may play a role in male pattern baldness.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

PPAR β/δ is important for skin health and disease treatment, but more research is needed.